Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism

CONTEXT: Conventional hypoparathyroidism treatment with oral calcium and active vitamin D is aimed at correcting hypocalcemia but does not address other physiologic defects caused by PTH deficiency. OBJECTIVE: To evaluate long-term safety and tolerability of recombinant human PTH (1-84) [rhPTH(1-84)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Mannstadt, Michael, Clarke, Bart L, Bilezikian, John P, Bone, Henry, Denham, Douglas, Levine, Michael A, Peacock, Munro, Rothman, Jeffrey, Shoback, Dolores M, Warren, Mark L, Watts, Nelson B, Lee, Hak-Myung, Sherry, Nicole, Vokes, Tamara J
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Clinical Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6760337/
https://ncbi.nlm.nih.gov/pubmed/31369089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2019-01010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars